CTC Clinical Trial Consultants
CTC Clinical Trial Consultants is recorded as a service provider in 8 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 8 of 8 trials · Latest update first
Psilocybin therapy for Psychological Distress in Palliative Care Patients (PsyPal)
Sponsor Universitair Medisch Centrum Groningen
- Start (EU)
- Latest update
- Estimated end
- Not reported
A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and immune response of single and multiple ascending doses of TOL2 (Immune Tolerising Agent) in patients with generalised myasthenia gravis
Sponsor Bonsai Biotherapeutics AB
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary efficacy of two dose levels of golexanolone in subjects with primary biliary cholangitis, fatigue, and cognitive dysfunction.
Sponsor Umecrine Cognition AB
- Start (EU)
- Latest update
- Estimated end
A two-part, randomised, double-blind, placebo-controlled, parallel-group, 12week trial investigating the safety, tolerability, pharmacokinetics and efficacy of XEN-D0501 in obese participants
Sponsor Pila Pharma AB
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With Renal Impairment Using Positron Emission Tomography (PET)
Sponsor AstraZeneca AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
DiaPrecise, A Phase II Open Label Study to evaluate the safety and feasibility of intralymphatic administration of Diamyd® in individuals at risk for Type 1 diabetes carrying the HLA DR3-DQ2 haplotype
Sponsor Diamyd Medical AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
MAATEO: A phase 1 study in patients with hematological malignancies to evaluate safety, tolerability and efficacy of Karonudib
Sponsor Oxcia AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and preliminary efficacy of single intraarticular injections of three dose levels of SYN321 and placebo in patients with symptomatic knee osteoarthritis
Sponsor Synartro AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for CTC Clinical Trial Consultants?
The 2026-10-09 snapshot links CTC Clinical Trial Consultants to 8 distinct CTIS trials. Recorded services include Clinical monitoring, Electronic data capture, Project management, Safety reporting & pharmacovigilance, among 13 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for CTC Clinical Trial Consultants?
The most frequently recorded therapeutic areas are Neurology, Gastroenterology, Hepatology, Immunology. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to CTC Clinical Trial Consultants conducted?
The linked trials record locations in 10 countries, including Sweden, Denmark, Germany, Czechia, Spain. These are trial locations, not confirmed office locations or countries where CTC Clinical Trial Consultants delivered services.
What can this page tell me about CTC Clinical Trial Consultants's trial experience?
Browse 8 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under CTC Clinical Trial Consultants. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- CTC Clinical Trial Consultants AB